Up-regulation of α2,6 sialylation during myeloid maturation: A potential role in myeloid cell release from the bone marrow

Journal of Cellular Physiology

Volumn 179, Issue 3, 1999, Pages 315-324

  Le Marer, Nadia ^a,b   Skacel, Patricia O ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; FIBRONECTIN; MEMBRANE PROTEIN; MESSENGER RNA; SIALIC ACID; SIALYLTRANSFERASE; BETA D GALACTOSIDE ALPHA 2 6 SIALYLTRANSFERASE; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; CD11 ANTIGEN; CD34 ANTIGEN; FC RECEPTOR; MEMBRANE ANTIGEN; N ACETYLNEURAMINIC ACID;

ARTICLE; BONE MARROW; BONE MARROW CELL; CELL ADHESION; CELL INTERACTION; CELL MATURATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIALYLATION; STROMA; CELL DIFFERENTIATION; CELL MOTION; CHEMISTRY; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; IMMUNOLOGY; KINETICS; METABOLISM; NEUTROPHIL; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD11; ANTIGENS, CD34; ANTIGENS, SURFACE; BLOTTING, WESTERN; BONE MARROW CELLS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; FIBRONECTINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOSYLATION; HUMANS; KINETICS; N-ACETYLNEURAMINIC ACID; NEUTROPHILS; RECEPTORS, IGG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALYLTRANSFERASES; UP-REGULATION;

EID: 0032587037     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199906)179:3<315::AID-JCP9>3.0.CO;2-U     Document Type: Article

References (45)

1. Aasheim C, Aas-Eng DA, Blomhoff HK, Funderud S, Smeland BB. 1993. Cell-specific expression of human β-galactoside α2,6 sialyltransferase transcripts differing in the 5′untranslated region. Eur J Biochem 213:467-475.
2. Baker M, Taub R, Whelton C, Hindenburg, A 1984. Aberrant sialylation of granulocyte membranes in chronic myelogenous leukemia. Blood 63:1194-1197.
3. Baker MA, Taub RN, Kanani A, Brockhausen I, Hindenburg A. 1985. Increased activity of a specific sialyltransferase in chronic myelogenous leukemia. Blood 66:1068-1071.
4. Bast BJEG, Zhou LJ, Freeman GJ, Colley KJ, Ernst TJ, Munro JM, Tedder TF. 1992. The HB-6, CDw75 and CD76 differentiation antigens are unique cell surface carbohydrate determinants generated by the β-galactoside α2,6sialyltransferase. J Cell Biol 116:423-435.
5. Baum LG, Derbin K, Perillo NL, Wu T, Pang M, Uittenbogaart C. 1996. Characterisation of terminal sialic acid linkages on human thymocytes. J Biol Chem 271:10793-10799.
6. Bolscher J, van der Bijl M, Neefjes J, Hall A, Smets L, Ploegh H. 1987. Ras (proto)oncogene induces N-linked carbohydrate modification: temporal relationship with induction of invasive potential. EMBO J 7:3361-3368.
7. Butcher E. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033-1036.
8. Crocker P, Feizi T. 1996. Carbohydrate recognition systems: functional triads in cell-cell interactions. Curr Opin Struct Biol 6:679-691.
9. Crocker P, Freeman S, Gordon S, Kelm S. 1995. Sialoadhesin binds preferentially to cells of the granulocytic lineage. J Clin Invest 95:635-643.
10. Dennis J, Waller C, Timpl R, Schirrmacher V. 1982. Surface sialic acid reduces attachment of metastatic tumor cells to collagen type IV and fibronectin. Nature 300:274-276.
11. Diamond MS, Staunton DE, Marlin SD, Springer TA. 1991. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 65:961-971.
12. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner D. 1996. Susceptibility to infection and altered heamatopoiesis in mice deficient in both P-and E-selectin. Cell 84:563-574.
13. Grundmann U, Nerlich C, Rein T, Zettlmeissl G. 1990. Complete cDNA sequence encoding human β-galactoside α-2,6-sialyltransferase. Nucleic Acid Res 18:667.
14. Hennet T, Chui D, Paulson J, Marth J. 1998. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 95:4504-4509.
15. Hughes R. 1994. Mac-2: a versatile galactose-binding protein of mammalian tissues. Glycobiology 4:5-12.
16. Joziasse D, Schiphorst W, van den Eijden D, van Kuik J, van Halbeek H, Vliegenthart J. 1987. Branch specificity of bovine colostrum CMP-sialic acid: Galβ1-4GlcNAc α2,6-sialyltransferase. J Biol Chem 262:2025-2033.
17. Kaneko Y, Yamamoto H, Colley K, Moskal J. 1995. Expression of Galβ1,4Glc NACα2,6-sialyltransferase and α2,6-linked sialoglycoconjugates in normal human and rat tissues. J Histochem Cytochem 43:945-954.
18. Kansas G. 1996. Selectins and their ligands: current concepts and controversies. Blood 88:3259-3287.
19. Karakaniza M, Cavengh J, Gordon-Smith E, Gibson F. 1995. Adhesion molecule expression on CD34+ progenitor cells from normal and aplastic anaemia bone marrow. Br J Haematol 91:800-803.
20. Kawano T, Takasaki S, Tao T, Kobata A. 1993. Altered glycosylation of β1 integrins associated with reduced adhesiveness to fibronectin and laminin. Int J Cancer 53:91-96.
21. Kitagawa H, Paulson JC. 1994a. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem 269:17872-17878.
22. Kitagawa H, Paulson JC. 1994b. Cloning of a novel α2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate group. J Biol Chem 269:1394-1401.
23. Krugluger W, Frigeri LG, Lucas T, Schmer M, Forster O, Liu FT, Boltz-Nitulescu G. 1997. Galectin-3 inhibits granulocyte-macrophage colony stimulating factor (GM-CSF)-driven rat bone marrow cell proliferation and GM-CSF-induced gene transcription. Immunobiology 197:97-109.
24. Le Marer N, Stéhelin D. 1995. High α2,6 sialylation of N-Acetyllactosamine sequences in ras-transformed rat fibroblasts correlates with high invasive potential. Glycobiology 5:219-226.
25. Le Marer N, Palcic M, Clarke JL, Davies D, Skacel PO. 1997. Developmental regulation of α1,3 fucosyltransferase expression in CD34 positive progenitors and maturing myeloid cells isolated from normal human bone marrow. Glycobiology 7:357-365.
26. Lo NW, Lau JTP. 1996a. Novel heterogeneity exists in the 5′-untranslated region of the β-galactoside α2,6 sialyltransferase mRNAs in the human B-lymphoblastoid cell line, Louckes. Biochem Biophys Res Commun 228:380-385.
27. Lo NW, Lau JTP. 1996b. Transcription of the β-galactoside α2,6 sialyltransferase gene in B lymphocytes is directed by a separate and distinct promoter. Glycobiology 6:271-279.
28. Lundgren Akerlund E, Olofsson AM, Berger E, Arfors KE. 1993. CD11b/CD18-dependent polymorphonuclear leucocyte interaction with matrix proteins in adhesion and migration. Scand J Immunol 37:569-574.
29. Lund-Johansen F, Terstappen LWMM. 1993. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 54:47-55.
30. Pardi R, Bender J, Dettori C, Giannazza E, Engleman E. 1989. Heterogeneous distribution and transmembrane signaling properties of lymphocyte function-associated antigen (LFA-1) in human lymphocyte subsets. J Immunol 143:3157-3166.
31. Paulson JC, Weinstein J, Schauer A. 1989. Tissue-specific expression of sialyltransferases. J Biol Chem 264:10931-10934.
32. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. 1995. Apoptosis of T-cells mediated by galectin-1. Nature 378:736-739.
33. Powell L, Varki A. 1995. I-tye lectins. J Biol Chem 270:14243-14246.
34. Sasaki K, Watanabe E, Kawashima K, Sekine S, Dohi T, Oshima M, Hanai N, Nishi T, Hasegawa M. 1993. Expression cloning of a novel Galβ(1-3/1-4) GlcNAc α2,3-Sialyltransferase using lectin resistance selection. J Biol Chem 268:22782-22787.
35. Skacel PO, Edwards AJ, Harrison CT, Watkins WM. 1991. Enzymatic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6′-sialyltransferase. Blood 78:1452-1460.
36. Spertini O, Cordey AS, Monai N, Giuffre L, Schapira M. 1996. P-selectin ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34+ hematopoietic progenitor cells. J Cell Biol 135:523-531.
37. Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T. 1991. The B lymphocyte adhesion molecule CD22 interacts with the leukocyte common antigen CD45R0 on T cells and α2,6-sialyltransferase, CD75, on B cells. Cell 66:1133-1144.
38. Taub R, Baker M, Madyastha K. 1980. Masking of neutrophil surface lectin-binding sites in chronic myelogenous leukemia (CML). Blood 55:294-298.
39. Terstappen L, Stafford M, Loken M. 1990. Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 4:657-663.
40. Walzog B, Schuppan D, Heimpel C, Hafezi Moghadam A, Gaehtgens P, Ley K. 1995. The leukocyte integrin Mac-1 (CD11b/CD18) contributes to binding of human granulocytes to collagen. Exp Cell Res 218:28-38.
41. Wlasichuk K, Kashem M, Nikrad P, Bird P, Jiang C, Venot A. 1993. Determination of the specificities of rat liver Gal(β1-4)GlcNAc α2,6-sialyltransferase and Gal(β1-3/4)GlcNAc α2,3-sialyltransferase using synthetic modified acceptors. J Biol Chem 268:13971-13977
42. Yang RY, Hsu DK, Liu FT. 1996. Expression of galectin-3 modulates T-cell growth and apoptoais. Proc Natl Acad Sci USA 93:6737-6742.
43. Yeh J, Cummings R. 1997. Differential recognition of glycoprotein acceptors by terminal glycosyltransferases. Glycobiology 7:241-251.
44. Yogeeswaran G, Salk P. 1981. Metastatic potential is positively correlated with cell surface sialylation of culture murine tumor cell lines. Science 212:1514-1516.
45. Zannetino A, Berndt M, Butcher C, Vadas M, Simmons P. 1995. Primitive human hematopoietic progenitors adhere to P-selectin (CD62). Blood 85:3466-3477.